Products & ReviewLife Sciences
CA19-9
Recombinant or purified CA19-9 antigen, a sialylated Lewis blood group antigen, which is a widely used serum biomarker for pancreatic and gastrointestinal cancers.
CA19-9
Request Pricing
Receive your quote directly from the manufacturer.
CA19-9 is a tumor-associated carbohydrate antigen elevated in the blood of patients with pancreatic, colorectal, and other cancers. It is primarily used for monitoring disease progression and response to treatment, though not for screening. Our CA19-9 antigen is essential for developing and calibrating diagnostic immunoassays.
Key Features & Benefits:
- Highly Pure and Well-Characterized Antigen
- Ideal for Assay Calibration and as a Positive Control
- Used to Generate and Validate Anti-CA19-9 Antibodies
- Critical for IVD Assay Development
Relevant Applications:
- Calibration of Clinical CA19-9 Immunoassays
- Quality Control in Clinical Laboratories
- Pancreatic and Gastrointestinal Cancer Research
- Development of Point-of-Care Diagnostic Tests
